March 24, 2026 — Market Update: After last week’s brutal selloff, Indian markets bounced sharply today. Sensex rallied 1,372 points (+1.89%) to 74,068, and Nifty surged 400 points (+1.78%) to 22,912 as US-Iran tensions eased. But here’s the question every investor should ask: when the dust settles, which companies will still be standing tall?

The answer is deceptively simple: companies with consistent earnings growth. Not the ones with spectacular one-off quarters, not the cyclical winners that ride commodity booms, but the quiet compounders that deliver steady, predictable earnings growth — year after year, quarter after quarter.

Today, we’ll explore why earnings consistency is the most underrated predictor of multibagger returns, and how Indian investors can use this to build lasting wealth.

What Is Earnings Consistency — And Why Does It Matter?

Earnings consistency means a company grows its profits steadily over time, without wild swings. Think of it as the difference between a reliable salary and lottery winnings. One builds financial security; the other is unpredictable.

Academic research supports this powerfully. A study by Robert Novy-Marx at the University of Rochester found that companies with stable, growing earnings outperform the broader market by 4-6% annually over long periods. Why? Because:

• Predictability attracts institutional investors — FIIs and mutual funds love stocks they can model reliably
• Consistent earnings support PE re-rating — the market rewards reliability with higher multiples over time
• Compounding works best without interruption — one bad year can set back a decade of compounding

The “Never Disappoint” Framework: 5 Metrics to Measure Earnings Consistency

Here’s a practical framework you can apply to any Indian stock today:

Metric 1: Consecutive Quarters of YoY Profit Growth

Count how many consecutive quarters the company has grown its net profit year-over-year. The best compounders maintain streaks of 12-20+ quarters. A single quarter of decline breaks the streak and should prompt investigation.

Metric 2: Revenue Growth Volatility

Calculate the standard deviation of quarterly revenue growth rates over the last 3 years. Lower volatility = more consistent business. If revenue growth swings between -10% and +40%, the business is cyclical and unpredictable. If it stays between +10% and +25%, you have a compounder.

Metric 3: Operating Margin Stability

Track the operating margin over the last 20 quarters. If it stays within a 3-5 percentage point band (e.g., 18-23%), the business has genuine pricing power and cost control. Wild margin swings indicate commodity dependence or competitive pressure.

Metric 4: Cash Flow Conversion Ratio

Divide operating cash flow by net profit. For consistent earners, this ratio should be above 0.8 (ideally above 1.0) in most years. If a company reports growing profits but cash flow conversion is below 0.5, the earnings quality is suspect — profits may be driven by accounting rather than real cash.

Metric 5: The “Bad Year” Test

Look at the company’s worst year in the last decade. How bad was it? For truly consistent earners, even their worst year shows only a minor dip (10-15% decline) rather than a collapse. Companies that survive their worst year with dignity are built for the long term.

Indian Case Study: The Titan Biotech Earnings Journey

Titan Biotech Ltd (BSE: 524717, CMP: ~₹368) has delivered one of the most impressive earnings consistency stories in India’s small-cap space. The company has shown steady revenue and profit growth driven by its expanding portfolio of biotech products and growing export markets.

What makes Titan Biotech’s earnings story compelling:

• Steady topline growth from diversified product portfolio
• Improving operating margins reflecting pricing power
• Strong cash flow generation from quality earnings
• Minimal cyclicality — biotech/pharma demand is recession-resistant

The result? A stock that has delivered 326% returns in just one year — not from a one-off event, but from the market finally recognizing years of consistent, compounding earnings growth. This is the power of earnings consistency at work.

Why Cyclical Earnings Destroy Wealth

Many Indian investors get trapped in cyclical stocks — metals, commodities, real estate, airlines — because they look “cheap” on trailing PE ratios during peak earnings. But here’s the mathematical reality:

A company that earns ₹100 crore for 3 years, then loses ₹150 crore in year 4, has destroyed more value than it created. The compounding gets reset. The management takes on debt to survive. Expansion plans get shelved. Employees leave. It takes years to recover — if it recovers at all.

Contrast this with a company that earns ₹70 crore, then ₹85 crore, then ₹100 crore, then ₹115 crore. Less exciting in any single year, but over a decade, this steady compounder creates exponentially more wealth than the cyclical roller coaster.

How to Build a “Consistency Portfolio” — Practical Steps

Step 1: Screen for earnings streaks. Use Screener.in or Trendlyne to find companies with 5+ years of consecutive profit growth. This alone eliminates 80% of listed companies.

Step 2: Apply the 5-metric framework above. Score each company on the five consistency metrics. Only proceed with companies scoring 4 out of 5 or better.

Step 3: Check management quality. Consistent earnings don’t happen by accident — they require disciplined management with strong capital allocation skills, high promoter holding, and conservative financial practices.

Step 4: Value appropriately. Consistent earners deserve premium valuations. A company growing profits at 20% annually with high consistency is worth 30-40x PE — far more than a cyclical company with the same trailing earnings.

Step 5: Hold with patience. The magic of consistency only reveals itself over 5-10 year periods. Don’t be tempted to trade in and out based on quarterly results.

The F&O Trap: Why Traders Miss the Consistency Premium

F&O traders and intraday speculators are fundamentally incapable of capturing the earnings consistency premium. Why? Because consistency plays out over years, not minutes.

SEBI’s own data is devastating: 90% of F&O traders lose money. They pay lakhs in brokerage, STT, and slippage chasing daily price movements — while patient investors in consistent earners quietly build fortunes.

Think about it: if you had invested ₹1 lakh in a consistent 25% annual compounder 10 years ago, you’d have ₹9.3 lakh today — with zero effort, zero stress, zero brokerage. That’s the power of consistency over complexity.

Conclusion: The Boring Path to Extraordinary Wealth

In a market obsessed with the next big thing — the next IPO, the next sector rotation, the next market crash — the most powerful investment strategy is deceptively boring: buy companies with consistent earnings growth, run by quality management, and hold them for decades.

Today’s 1,372-point Sensex rally is exciting. But it’s the companies that deliver consistent earnings through crashes AND rallies that create real multibagger returns. Focus on earnings consistency. Build a portfolio of “never disappoint” companies. Let compounding do the heavy lifting.

Titan Biotech (BSE: 524717, CMP: ~₹368, up 326% in 1 year, PE: 56x) is a prime example of how earnings consistency gets rewarded by the market over time. Study it, learn from it, and apply the principles to your own portfolio.

🎓 Want to learn value investing from scratch? Watch our FREE 30-episode Value Investing Course: Click Here to Start Learning

Disclaimer: This article is for educational purposes only and does not constitute investment advice. The author and Manish Goel Portfolio Management Service are not SEBI Registered Research Analysts. Stock market investments are subject to market risks. Please consult a qualified financial advisor before making investment decisions. The mention of any stock, including Titan Biotech Ltd, is purely for educational illustration and should not be construed as a buy/sell recommendation.